nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—CHRM3—muscle of abdomen—ovarian cancer	0.216	0.247	CbGeAlD
Propiomazine—HTR2A—vein—ovarian cancer	0.0989	0.113	CbGeAlD
Propiomazine—DRD4—testis—ovarian cancer	0.0467	0.0533	CbGeAlD
Propiomazine—CHRM5—epithelium—ovarian cancer	0.046	0.0525	CbGeAlD
Propiomazine—ADRA1D—epithelium—ovarian cancer	0.0411	0.047	CbGeAlD
Propiomazine—CHRM4—testis—ovarian cancer	0.0353	0.0403	CbGeAlD
Propiomazine—ADRA1D—female reproductive system—ovarian cancer	0.0306	0.0349	CbGeAlD
Propiomazine—ADRA1A—epithelium—ovarian cancer	0.0236	0.027	CbGeAlD
Propiomazine—HRH1—myometrium—ovarian cancer	0.0233	0.0266	CbGeAlD
Propiomazine—HTR2C—female reproductive system—ovarian cancer	0.0226	0.0258	CbGeAlD
Propiomazine—CHRM1—female reproductive system—ovarian cancer	0.0214	0.0244	CbGeAlD
Propiomazine—CHRM3—female reproductive system—ovarian cancer	0.0191	0.0218	CbGeAlD
Propiomazine—HTR2A—embryo—ovarian cancer	0.0187	0.0214	CbGeAlD
Propiomazine—HRH1—epithelium—ovarian cancer	0.0183	0.0209	CbGeAlD
Propiomazine—HRH1—uterine cervix—ovarian cancer	0.0181	0.0207	CbGeAlD
Propiomazine—CHRM3—female gonad—ovarian cancer	0.0174	0.0199	CbGeAlD
Propiomazine—HRH1—decidua—ovarian cancer	0.0173	0.0197	CbGeAlD
Propiomazine—HRH1—endometrium—ovarian cancer	0.0164	0.0187	CbGeAlD
Propiomazine—CHRM3—testis—ovarian cancer	0.0154	0.0176	CbGeAlD
Propiomazine—HTR2A—epithelium—ovarian cancer	0.0153	0.0174	CbGeAlD
Propiomazine—DRD2—testis—ovarian cancer	0.0139	0.0158	CbGeAlD
Propiomazine—HRH1—female reproductive system—ovarian cancer	0.0136	0.0155	CbGeAlD
Propiomazine—HTR2A—gonad—ovarian cancer	0.0127	0.0145	CbGeAlD
Propiomazine—HRH1—female gonad—ovarian cancer	0.0124	0.0141	CbGeAlD
Propiomazine—HRH1—vagina—ovarian cancer	0.0123	0.014	CbGeAlD
Propiomazine—HTR2A—female reproductive system—ovarian cancer	0.0113	0.013	CbGeAlD
Propiomazine—HRH1—testis—ovarian cancer	0.011	0.0125	CbGeAlD
Propiomazine—HTR2A—vagina—ovarian cancer	0.0103	0.0117	CbGeAlD
Propiomazine—HTR2A—testis—ovarian cancer	0.00916	0.0105	CbGeAlD
Propiomazine—HRH1—lymph node—ovarian cancer	0.00795	0.00907	CbGeAlD
Propiomazine—Diltiazem—ABCB1—ovarian cancer	0.00254	0.154	CrCbGaD
Propiomazine—Triflupromazine—ABCB1—ovarian cancer	0.00226	0.137	CrCbGaD
Propiomazine—Fluphenazine—ABCB1—ovarian cancer	0.00174	0.106	CrCbGaD
Propiomazine—Clomipramine—ABCB1—ovarian cancer	0.00159	0.0967	CrCbGaD
Propiomazine—Chlorprothixene—ABCB1—ovarian cancer	0.00158	0.0963	CrCbGaD
Propiomazine—Trimipramine—ABCB1—ovarian cancer	0.00146	0.089	CrCbGaD
Propiomazine—Promethazine—ABCB1—ovarian cancer	0.00141	0.0856	CrCbGaD
Propiomazine—Trifluoperazine—ABCB1—ovarian cancer	0.00139	0.0845	CrCbGaD
Propiomazine—Methadone—ABCB1—ovarian cancer	0.00139	0.0843	CrCbGaD
Propiomazine—Chlorpromazine—ABCB1—ovarian cancer	0.00109	0.0663	CrCbGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CB—ovarian cancer	1.98e-05	0.000184	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCND1—ovarian cancer	1.97e-05	0.000183	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MTOR—ovarian cancer	1.96e-05	0.000183	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	1.96e-05	0.000183	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MAPK3—ovarian cancer	1.96e-05	0.000182	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	1.96e-05	0.000182	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	1.96e-05	0.000182	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—KRAS—ovarian cancer	1.96e-05	0.000182	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CTNNB1—ovarian cancer	1.95e-05	0.000182	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CXCL8—ovarian cancer	1.95e-05	0.000182	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—AKT1—ovarian cancer	1.94e-05	0.00018	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HRAS—ovarian cancer	1.94e-05	0.00018	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MYC—ovarian cancer	1.93e-05	0.00018	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	1.92e-05	0.000179	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CXCL8—ovarian cancer	1.92e-05	0.000178	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MMP9—ovarian cancer	1.92e-05	0.000178	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CXCL8—ovarian cancer	1.91e-05	0.000178	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MYC—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CXCL8—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HRAS—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTEN—ovarian cancer	1.91e-05	0.000177	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HRAS—ovarian cancer	1.9e-05	0.000177	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HRAS—ovarian cancer	1.89e-05	0.000176	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MAPK1—ovarian cancer	1.89e-05	0.000176	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EGFR—ovarian cancer	1.89e-05	0.000176	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	1.89e-05	0.000175	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	1.89e-05	0.000175	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	1.88e-05	0.000175	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	1.88e-05	0.000174	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	1.87e-05	0.000174	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—KRAS—ovarian cancer	1.87e-05	0.000174	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CDKN1B—ovarian cancer	1.87e-05	0.000174	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	1.87e-05	0.000174	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CASP3—ovarian cancer	1.87e-05	0.000174	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CDKN1B—ovarian cancer	1.87e-05	0.000174	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL2—ovarian cancer	1.87e-05	0.000173	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MAPK1—ovarian cancer	1.87e-05	0.000173	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EGFR—ovarian cancer	1.87e-05	0.000173	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CDKN1B—ovarian cancer	1.86e-05	0.000173	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—AKT1—ovarian cancer	1.86e-05	0.000173	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL6—ovarian cancer	1.86e-05	0.000173	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	1.86e-05	0.000173	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—AKT1—ovarian cancer	1.85e-05	0.000172	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—AKT1—ovarian cancer	1.85e-05	0.000172	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—AKT1—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CASP3—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL2—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CASP3—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL2—ovarian cancer	1.83e-05	0.00017	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CASP3—ovarian cancer	1.83e-05	0.00017	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL6—ovarian cancer	1.83e-05	0.00017	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL2—ovarian cancer	1.83e-05	0.00017	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CASP3—ovarian cancer	1.82e-05	0.00017	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL6—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PIK3CA—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL2—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCND1—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL6—ovarian cancer	1.82e-05	0.000169	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL6—ovarian cancer	1.81e-05	0.000168	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CASP3—ovarian cancer	1.81e-05	0.000168	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL2—ovarian cancer	1.8e-05	0.000168	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	1.8e-05	0.000167	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	1.8e-05	0.000167	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PIK3CA—ovarian cancer	1.8e-05	0.000167	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL2—ovarian cancer	1.8e-05	0.000167	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	1.8e-05	0.000167	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL6—ovarian cancer	1.79e-05	0.000167	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCND1—ovarian cancer	1.79e-05	0.000166	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	1.79e-05	0.000166	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCND1—ovarian cancer	1.79e-05	0.000166	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—KRAS—ovarian cancer	1.79e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCND1—ovarian cancer	1.78e-05	0.000166	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—STAT3—ovarian cancer	1.78e-05	0.000165	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NRAS—ovarian cancer	1.78e-05	0.000165	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCND1—ovarian cancer	1.78e-05	0.000165	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	1.77e-05	0.000165	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	1.77e-05	0.000164	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MMP9—ovarian cancer	1.77e-05	0.000164	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	1.76e-05	0.000164	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—ovarian cancer	1.76e-05	0.000164	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—KRAS—ovarian cancer	1.76e-05	0.000164	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCND1—ovarian cancer	1.76e-05	0.000163	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CTNNB1—ovarian cancer	1.76e-05	0.000163	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTEN—ovarian cancer	1.76e-05	0.000163	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	1.75e-05	0.000163	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	1.74e-05	0.000162	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—ovarian cancer	1.74e-05	0.000162	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MMP9—ovarian cancer	1.74e-05	0.000162	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	1.74e-05	0.000161	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MMP9—ovarian cancer	1.73e-05	0.000161	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MMP9—ovarian cancer	1.73e-05	0.000161	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTEN—ovarian cancer	1.73e-05	0.000161	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTEN—ovarian cancer	1.72e-05	0.00016	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MMP9—ovarian cancer	1.72e-05	0.00016	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PIK3CA—ovarian cancer	1.72e-05	0.00016	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	1.72e-05	0.00016	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTEN—ovarian cancer	1.72e-05	0.00016	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	1.71e-05	0.000159	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTEN—ovarian cancer	1.71e-05	0.000159	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	1.71e-05	0.000159	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	1.69e-05	0.000157	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HRAS—ovarian cancer	1.69e-05	0.000157	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	1.69e-05	0.000157	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	1.68e-05	0.000156	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	1.68e-05	0.000156	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	1.67e-05	0.000155	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—ovarian cancer	1.67e-05	0.000155	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HRAS—ovarian cancer	1.66e-05	0.000155	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	1.66e-05	0.000154	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MYC—ovarian cancer	1.65e-05	0.000154	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	1.65e-05	0.000153	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	1.64e-05	0.000153	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	1.63e-05	0.000151	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	1.62e-05	0.00015	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	1.62e-05	0.00015	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	1.62e-05	0.00015	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL6—ovarian cancer	1.61e-05	0.00015	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HRAS—ovarian cancer	1.59e-05	0.000148	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL6—ovarian cancer	1.59e-05	0.000148	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—ovarian cancer	1.59e-05	0.000148	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	1.59e-05	0.000147	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	1.58e-05	0.000147	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—STAT3—ovarian cancer	1.57e-05	0.000146	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NRAS—ovarian cancer	1.57e-05	0.000146	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—ovarian cancer	1.57e-05	0.000146	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	1.56e-05	0.000145	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	1.56e-05	0.000145	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—STAT3—ovarian cancer	1.54e-05	0.000143	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	1.54e-05	0.000143	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NRAS—ovarian cancer	1.54e-05	0.000143	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	1.54e-05	0.000143	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	1.53e-05	0.000143	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	1.53e-05	0.000142	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	1.53e-05	0.000142	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	1.53e-05	0.000142	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	1.53e-05	0.000142	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	1.53e-05	0.000142	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL6—ovarian cancer	1.53e-05	0.000142	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HRAS—ovarian cancer	1.52e-05	0.000141	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	1.52e-05	0.000141	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	1.51e-05	0.000141	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	1.51e-05	0.000141	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	1.51e-05	0.00014	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	1.5e-05	0.000139	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	1.5e-05	0.000139	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—AKT1—ovarian cancer	1.49e-05	0.000138	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	1.48e-05	0.000137	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	1.47e-05	0.000137	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—AKT1—ovarian cancer	1.47e-05	0.000137	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	1.47e-05	0.000137	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	1.46e-05	0.000136	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	1.46e-05	0.000136	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MYC—ovarian cancer	1.46e-05	0.000136	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL6—ovarian cancer	1.45e-05	0.000135	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	1.45e-05	0.000135	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	1.45e-05	0.000134	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PIK3CA—ovarian cancer	1.45e-05	0.000134	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MYC—ovarian cancer	1.44e-05	0.000133	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL6—ovarian cancer	1.43e-05	0.000133	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MYC—ovarian cancer	1.43e-05	0.000133	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MYC—ovarian cancer	1.43e-05	0.000133	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	1.43e-05	0.000133	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EGFR—ovarian cancer	1.43e-05	0.000133	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MYC—ovarian cancer	1.42e-05	0.000132	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MYC—ovarian cancer	1.41e-05	0.000131	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—AKT1—ovarian cancer	1.41e-05	0.000131	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	1.41e-05	0.000131	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	1.41e-05	0.000131	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	1.4e-05	0.000131	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	1.4e-05	0.00013	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	1.4e-05	0.00013	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EGFR—ovarian cancer	1.4e-05	0.00013	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	1.4e-05	0.00013	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	1.4e-05	0.00013	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	1.39e-05	0.000129	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	1.39e-05	0.000129	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	1.38e-05	0.000128	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	1.38e-05	0.000128	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	1.38e-05	0.000128	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	1.38e-05	0.000128	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—ovarian cancer	1.36e-05	0.000126	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—KRAS—ovarian cancer	1.35e-05	0.000125	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	1.34e-05	0.000125	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—AKT1—ovarian cancer	1.34e-05	0.000125	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	1.33e-05	0.000123	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—KRAS—ovarian cancer	1.32e-05	0.000123	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	1.32e-05	0.000123	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	1.32e-05	0.000123	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	1.32e-05	0.000122	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	1.3e-05	0.000121	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	1.3e-05	0.000121	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	1.3e-05	0.000121	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	1.3e-05	0.000121	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	1.24e-05	0.000116	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL6—ovarian cancer	1.24e-05	0.000116	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	1.24e-05	0.000115	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	1.22e-05	0.000113	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	1.22e-05	0.000113	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-05	0.000113	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-05	0.000112	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—ovarian cancer	1.2e-05	0.000111	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	1.2e-05	0.000111	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	1.19e-05	0.000111	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	1.19e-05	0.000111	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—AKT1—ovarian cancer	1.18e-05	0.00011	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—ovarian cancer	1.18e-05	0.00011	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—ovarian cancer	1.18e-05	0.000109	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—ovarian cancer	1.17e-05	0.000109	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—ovarian cancer	1.17e-05	0.000109	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—ovarian cancer	1.16e-05	0.000108	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	1.15e-05	0.000107	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	1.15e-05	0.000107	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HRAS—ovarian cancer	1.15e-05	0.000107	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	1.13e-05	0.000105	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HRAS—ovarian cancer	1.13e-05	0.000105	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	1.12e-05	0.000104	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	1.12e-05	0.000104	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	1.11e-05	0.000103	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	1.1e-05	0.000103	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	1.1e-05	0.000102	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL6—ovarian cancer	1.1e-05	0.000102	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL6—ovarian cancer	1.08e-05	0.0001	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL6—ovarian cancer	1.08e-05	0.0001	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL6—ovarian cancer	1.07e-05	9.98e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL6—ovarian cancer	1.07e-05	9.95e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL6—ovarian cancer	1.06e-05	9.85e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	1.06e-05	9.82e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—AKT1—ovarian cancer	1.01e-05	9.41e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	9.96e-06	9.26e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—AKT1—ovarian cancer	9.94e-06	9.24e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	9.91e-06	9.21e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	9.88e-06	9.18e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	9.78e-06	9.09e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	9.75e-06	9.06e-05	CbGpPWpGaD
